Cookies on the
LGC website
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on the LGC website. However, if you would like to, you can change your cookie settings at anytime.
Question markFind out more

08 Oct LGC ranks 54 in Sunday Times’ business standings

The 2018 ranking is an improvement on last year’s rank of 63

01 Oct LGC invests in new GMP analytical capability

Significant investment at Kulmbach site expands capacity of specialist therapeutic oligonucleotide development solutions business

27 Sep LGC acquires Berry & Associates

Investment follows other acquisitions in oligonucleotide reagent and synthesised oligonucleotides markets

01 Jun Julian Braybrook appointed UK Government Chemist

Replaces Dr Derek Craston, who completed two terms of five years each in this Office

16 Feb LGC acquires Lucigen, strengthening its reagents offering to the genomics market

Lucigen offers extensive enzymology expertise and a wide portfolio of molecular biology reagents